AI in pharma state of play report 2026

Our second annual AI in pharma state of play report is based on 20 in-depth interviews with Insights and Analytics leaders across 10 pharma organisations in Europe and the US.

Access to AI is no longer the barrier it was last year. The real test now is whether that access is translating into commercial value, and this year’s report shows where that’s genuinely happening and where enthusiasm is still ahead of proof.

Download now to discover:

• Why proving ROI has become the new differentiator between teams pulling ahead and teams starting to stall
• What’s really holding AI back – and why it’s the data underneath it, not the technology itself
• How advanced pharma teams are building governance that helps people move faster and safer, not slower
• Which of the four AI adopter profiles matches your team – from ‘Cautious’ to ‘Constrained Change Seeker’